About Us
Our Partnership
Key Structures
Engage With Us
Topics
Replenishment
Our Financing
Results & Data
Impact Stories
The “Pink Girls” of Zambia: Breaking Down HIV Silence and Stigma
An Invisible Line of Defense: How Laboratory Workers in Asia-Pacific Protect Against the Next Pandemic
Global Health Security
A Decade of Progress: Halting Drug-Resistant Malaria in Southeast Asia
Media Resources
News Releases
Opinion
Publication Categories
Resources
Approved by the Board on: 11 May 2021
Based on the recommendation of the Audit and Finance Committee, the Board approves the increase of forecasted aggregate operating expenses available for the 2020-2022 allocation period by US$ 30 million, in order to facilitate the implementation of critical activities in 2022; such that the amount made available for operating expenses for the 2020-2022 allocation cycle shall be US$ 930 million.